Plant variety rights: what to register, when, and why it is rarely as simple as it looks
On paper, a plant variety right is a form and a fee. In practice it is a series of decisions about what to protect, where, and when, and the deadlines and the local rules are unforgiving. Here is what actually matters.
Registering a plant variety right looks like an administrative task. You fill in a form, propose a name, send a sample, pay a fee. That impression is where a great deal of value quietly goes missing. A plant variety right is a commercial asset, and the decisions that set how much it is worth, or whether you can get one at all, are made long before the form is submitted.
This is a practical tour of what a plant variety right is, what a good application is made of, and why two countries that signed the same treaty can still treat your variety completely differently. None of it is hard once you can see it. The cost of not seeing it can be a variety you are no longer able to protect.
What a plant variety right actually protects
A plant variety right, often called plant breeders' rights or PVR, is an intellectual property right for a new plant variety. It gives the breeder, or whoever holds the right, control over the propagating material of that variety: the seed, cuttings or young plants used to reproduce it. Some systems reach further, to the harvested material and even to products made from it, but that reach varies by country, and we will come back to it.
It is not a patent and not a trademark. A patent protects a technical invention such as a gene or a trait. A trademark protects a brand. A plant variety right protects the whole variety, the specific combination of characteristics that makes it what it is. Most successful varieties on the market actually rest on two or three of these rights at once, which is the first hint that protection is a strategy question rather than a filing one. The patent side has its own moving parts, and we cover those separately.
The four things a variety has to be
To qualify, a variety has to clear four tests. Three of them travel together as DUS:
- Distinct. It is clearly different from any variety already in common knowledge.
- Uniform. Its plants are consistent with each other, allowing for the normal variation of how it is propagated.
- Stable. It stays the same after repeated propagation, season after season.
The fourth test is novelty, and it is the one that catches people out.
The deadline almost nobody watches
Novelty does not mean never sold. It means not sold too early. A variety stays novel as long as the breeder has not sold or disposed of it for commercial purposes beyond a grace period: more than one year inside the country where you are filing, or more than four years outside it, and six years for trees and vines. In the EU system that grace period is set by Article 10 of Regulation 2100/94; in the UPOV 1991 Act it is Article 6.
Read it twice, because it cuts both ways.
We have sat across the table from breeders who were sure they had missed their chance. They had sold the variety abroad, assumed that closed the door, and stopped thinking about protection. The door was still open. The four-year foreign window had not run, and they could still have filed across most of the world. By the time they understood that, the four years had quietly expired, and the novelty they could have protected was gone for good. Their error had nothing to do with selling abroad. It was failing to start the grace-period clock the day they made the sale.
Novelty is not lost the day you sell. It is lost the day you stop counting.
The habit that prevents it is simple. The moment a variety is sold or trialled commercially anywhere, the clock starts, and the filing plan is built around it.
What a good application is actually made of
When the application goes in, it is built from a few distinct parts, and each carries its own decisions.
The first is breeder identity. Who bred the variety and who holds the right are not always the same party, and getting the chain of title clear at the start saves a painful unwind later.
Then the denomination, the official name of the variety, which comes with a trap we watch people spring again and again. A denomination is a generic name, and by law it has to stay free for anyone to use when referring to the variety, even after the right expires. So if you make your denomination the same word as your consumer trademark, you hand that word to the public for that variety and hollow out the brand you were trying to build. Article 18(1) of Regulation 2100/94 and Article 20 of the UPOV 1991 Act are explicit about it. The fix is to keep the two apart: a neutral denomination for the variety, a separate brand for the shelf. The apple most shoppers know as Pink Lady® is the clean example. Pink Lady is the trademark; the variety itself is Cripps Pink. One the owner controls, the other anyone may use.
Next comes the technical questionnaire and the DUS examination. You set out the variety's botanical details and breeding history, and an authority grows it out to confirm it really is distinct, uniform and stable. It sounds mechanical, but which characteristics you lead with, and which reference varieties you are measured against, can decide whether you clear distinctness at all.
Last is priority. File in one member of the system and you have twelve months to file elsewhere while keeping your original date, under Article 52 of the EU regulation and Article 11 of UPOV 1991. Twelve months feels generous until a launch slips.
UPOV sets the frame, and each country fills it in differently
Most of what we have covered comes from UPOV, the international convention that gives plant variety protection a shared shape across its members. It is why the criteria look familiar wherever you go. It is also where many people stop reading, and where the expensive surprises live, because UPOV draws the frame and each country fills it in its own way.
A few examples, not as a legal survey, only to show the spread.
In China, a granted plant variety right does not by itself let you sell the variety. You also have to clear a separate administrative registration or recording step before you can advertise or sell, and China will not accept a foreign growing-trial report, so material has to be re-tested locally, including a quarantine period that can add years for a foreign applicant.
The scope of the right moves too. The EU system and some others can reach harvested material, and in defined cases the products made from it, while China has no concept of harvested material and Brazil leaves it undefined, so protection there effectively stops at the propagating material. Whether you can act against someone selling the fruit, rather than the plants, can depend entirely on which border you are standing at.
What you can stop, and where, can change at every border.
Enforcement carries very different teeth. In Greece and Italy, infringing a plant variety right is a civil matter. Cross into Ukraine and the same act can be a criminal offence carrying years in prison. Even the farmers' privilege, the right to save seed, is not as universal as people assume: a variety registered through the EU can be subject to it, while the same variety registered only nationally in Italy may not be, which quietly hands the breeder more control.
None of this means you need a lawyer in nine countries. It means that where you file, and in what order, is a commercial decision with real money attached, and it deserves to be made on purpose.
Why this is a strategy, not a form
Put the pieces together and the shape is clear. The hard parts of plant variety protection sit around the form, not inside it: when the novelty clock is running, how the denomination and the brand are kept apart, which countries are worth the cost and in what sequence, and how the right sits alongside any patents and trademarks on the same variety.
This is where we see good varieties lose value, and it is rarely bad luck, more often advice that stopped at the paperwork. Plenty of agents will file a competent application and never raise the questions above, because filing is the service they sell. The breeder learns what was missed when it is too late and too costly to fix.
At Greenstone we come at this from the commercial side first. The aim is plain: the most protection for the least cost, with the strategy settled before the deadlines settle it for you. We help breeders, IP holders and the companies that commercialise varieties decide what to protect, where, and when, so the right ends up worth what the variety is worth. If you have a variety in the ground or on the way, the conversation worth having is the one before the first sale, not the one after it.
Frequently asked questions
What are the requirements for a plant variety right?
A variety must be novel and meet the DUS criteria: distinct from existing varieties, uniform across its plants, and stable over repeated propagation. Novelty carries a time limit, so timing matters as much as the qualities of the plant.
Can I still apply if I have already sold the variety?
Often, yes. A variety stays novel for up to one year of sales inside the country of filing and up to four years outside it (six years for trees and vines). Many breeders assume an early sale ends their chance when the foreign window is still open, so check the grace period the moment you make a first sale.
Can I use my trademark as the variety name?
It is a costly mistake. The variety denomination is a generic name that must stay free for everyone to use, so making it identical to your trademark effectively pushes that word into the public domain for the variety. Keep them separate, as with Cripps Pink (the denomination) and Pink Lady® (the trademark).
Does one plant variety right cover every country?
No. UPOV gives the system a common shape, but protection is granted country by country, or through regional offices like the EU's, and the scope, examination, enforcement and even farmers' rights differ by jurisdiction. Where and in what order you file is a commercial decision.
What is the difference between a plant variety right and a patent?
A plant variety right protects a whole variety; a patent protects a technical invention such as a gene or trait. Many varieties carry both, plus a trademark, which is why protection is best planned as one combined strategy.
Book a free 30-minute session
Sitting on a variety and unsure what to protect, where, or by when? In a free 30-minute session, we will sketch the commercial shape of it with you, before a deadline decides for you.
Related topics
More insights
When others want to trial your variety, get it right or everyone loses
A plant variety trial is a step toward commercialisation, not commercialisation itself. Protect the breeder's novelty, and set up the licence the trial could unlock.
Strategy before registration: the right order for plant variety IP
Filing plant variety rights before you have a commercial strategy wastes budget and weakens your position. Here is how to get the order right.
How to commercialise a new plant variety: choosing the route that pays
The decision that sets what a new variety earns is how you commercialise it. The main licensing models, the royalty stack, and the sequence that protects the value.

About the author
Tomer Biran, Founder of Greenstone
Tomer Biran is the founder of Greenstone. He has spent more than twenty years on both sides of the table: as a qualified lawyer and former General Counsel to international organisations across multiple jurisdictions, and as a founder and operator of B2B and B2C businesses across the UK, EU, and US. He has served as General Manager of a leading plant breeders' company with a global footprint and as General Counsel of an international fresh produce marketing group. He holds a Master of Law and Business from WHU and Bucerius Law School in Hamburg, where he was a Joachim Herz Excellence Scholar, and a Bachelor of Laws. That blend of commercial operating experience and legal depth is what drives Greenstone's commercial-first approach to plant variety rights and commercialisation.
Connect on LinkedIn